» Articles » PMID: 22851996

Serum Concentrations of Adiponectin, Leptin, Resistin, Ghrelin and Insulin and Their Association with Obesity Indices in Obese Normo- and Hypertensive Patients - Pilot Study

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2012 Aug 2
PMID 22851996
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hypertension often coexists with obesity. Adipokines, ghrelin and insulin play important roles in the pathogenesis of both diseases. The aim of this study was to compare adiponectin, leptin, resistin, insulin and ghrelin mean serum concentrations and insulin resistance (HOMA-IR) in normo- and hypertensive patients with obesity.

Material And Methods: ALL INCLUDED PATIENTS WERE DIVIDED ON THE FOLLOWING GROUPS: non-diabetic hypertensive patients with class I obesity (group A, n = 21) and class II/III obesity (group B, n = 10), and normotensive obese (class I)patients (group C, n = 7). Correlations between obesity indices (body mass index [BMI], waist-to-hip ratio [WHR], waist circumference [WC]), HOMA-IR, and hormone and adipokine serum levels were also analyzed.

Results: Leptin level and HOMA-IR were significantly higher in group B compared to group C (9.74 ±3.88 ng/ml vs. 4.53 ±3.00 ng/ml; p < 0.02 and 3.30 ±1.59 vs. 1.65 ±0.41; p < 0.02, respectively). A negative correlation between WC and adiponectin level (R = -0.6275; p < 0.01) and a positive correlation between WC and insulin concentration (R = 0.5122; p< 0.05) as well as with HOMA-IR (R = 0.5228; p < 0.02) were found in group A. Negative correlations between BMI and ghrelin level (R = -0.7052; p < 0.05), WHR and adiponectin level (R = -0.6912; p < 0.05) and WHR and leptin level (R = -0.6728; p < 0.05) were observed in group B.

Conclusions: Insulin resistance and leptin may be important pathogenic factors in hypertensive patients with severe obesity. Indices of abdominal obesity (WC, WHR) correlate better than BMI with HOMA-IR, insulin, adiponectin and leptin serum levels in hypertensive obese patients.

Citing Articles

The role of captopril in leukotriene deficient type 1 diabetic mice.

Guimaraes J, Queiroz L, Menikdiwela K, Pereira N, Ramalho T, Jancar S Sci Rep. 2023; 13(1):22105.

PMID: 38092813 PMC: 10719306. DOI: 10.1038/s41598-023-49449-8.


Assessment of Metabolic Parameters in Female Triathletes with Hashimoto's Thyroiditis in Poland.

Gierach M, Junik R Biomedicines. 2023; 11(3).

PMID: 36979748 PMC: 10045185. DOI: 10.3390/biomedicines11030769.


Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.

Mir M, Mir R, Alghamdi M, Wani J, Sabah Z, Jeelani M J Pers Med. 2022; 12(5).

PMID: 35629157 PMC: 9143828. DOI: 10.3390/jpm12050735.


Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises.

Assidi M, Yahya F, Al-Zahrani M, Elkhatib R, Zari A, Elaimi A Int J Mol Sci. 2021; 22(23).

PMID: 34884678 PMC: 8657586. DOI: 10.3390/ijms222312872.


Body Composition and Serum Anti-Müllerian Hormone Levels in Euthyroid Caucasian Women With Hashimoto Thyroiditis.

Adamska A, Poplawska-Kita A, Siewko K, Lebkowska A, Krentowska A, Buczynska A Front Endocrinol (Lausanne). 2021; 12:657752.

PMID: 34393994 PMC: 8358788. DOI: 10.3389/fendo.2021.657752.


References
1.
Diaz M . Hypertension and obesity. J Hum Hypertens. 2002; 16 Suppl 1:S18-22. DOI: 10.1038/sj.jhh.1001335. View

2.
Soufi M, Sattler A, Herzum M, Maisch B, Schaefer J . Molecular basis of obesity and the risk for cardiovascular disease. Herz. 2006; 31(3):200-6. DOI: 10.1007/s00059-006-2801-2. View

3.
Barylski M, Malyszko J, Rysz J, Mysliwiec M, Banach M . Lipids, blood pressure, kidney - what was new in 2011?. Arch Med Sci. 2012; 7(6):1055-66. PMC: 3265000. DOI: 10.5114/aoms.2011.26620. View

4.
Banach M, Goch J, Ugurlucan M, Rysz J, Mikhailidis D . Obesity and postoperative atrial fibrillation. Is there no connection? Comment on: Wanahita et al. "atrial fibrillation and obesity--results of a meta-analysis". Am Heart J. 2008; 156(1):e5. DOI: 10.1016/j.ahj.2008.03.028. View

5.
Tahira K, Ueno T, Fukuda N, Aoyama T, Tsunemi A, Matsumoto S . Obesity alters the expression profile of clock genes in peripheral blood mononuclear cells. Arch Med Sci. 2012; 7(6):933-40. PMC: 3264983. DOI: 10.5114/aoms.2011.26603. View